points in the B Corp recertification, making us the pharmaceutical company with the highest score in the world

We reinvested

more than the previous year in social and environmental projects

turnover

countries in which our products are present

of

expenditure/turnover with business partners assessed using ESG criteria

of the Management Committee are women, along with 45% of managerial positions

employees (48% women)

points WELL Platinum certification in corporate offices

hours of training

of our operational sites in Spain certified to ISO 45001

2 therapeutic focus areas:

pulmonary vascular and interstitial lung diseases and rare neurodegenerative diseases

investment in R&D

investment in industrial assets

units produced

patents (347 granted and 108 pending)

of electricity comes from renewable sources

waste recovery globally

reduction in water use at our sites  compared with last year)

of our cardboard and paper packaging sourced without deforestation

of our sites certified to ISO 14001

of our sites certified LEED

donated to social and environmental projects

hours of volunteering

volunteer participation

meals delivered per year to around 60 social organisations working with vulnerable groups

tonnes of products purchased from local producers